Demant announces strong half-year results with 15% revenue growth
The Group achieved 7% organic growth and increased EBIT before special items by 15%. CEO Søren Nielsen also previews the new Oticon Reveal hearing aid with Dual AI.
See the latest news and media coverage for Demant. We track all announcements, press releases, and industry mentions in real time, all in one place.
Global hearing healthcare products and services group
demant.comLast updated
In short: Demant reported 15% revenue growth in H1 2026, upgraded its annual outlook, and launched the AI-powered Oticon Reveal hearing solution.
The Group achieved 7% organic growth and increased EBIT before special items by 15%. CEO Søren Nielsen also previews the new Oticon Reveal hearing aid with Dual AI.
He joined on June 1 and will also serve on the Executive Leadership Team, allowing Søren Nielsen to focus as CEO.
Bassel Rifai joins as President of Hearing Aids from 1 June 2026. Søren Nielsen focuses on CEO role after Demant's growth.
CEO Søren Nielsen highlights 6% organic revenue growth, impact of OticonZeal hearing aids, and contributions from all business areas. He outlines positioning for coming months.
Demant-owned Oticon announces launch of new flagship Oticon Reveal. Nasdaq News. August 11, 2026.
Several financial houses have on Thursday been out and raised their price targets on the stock of the Danish hearing aid manufacturer Demant. This happens in the wake of Demant on Tuesday...
Morningstar is an investment research company offering mutual fund, ETF, and stock analysis, ratings, and data, and portfolio tools. Discover actionable insights today.
Demant has bought the Italian company Amplifon's British hearing clinics, thereby significantly expanding its own retail business in the UK. This is reported by the industry media . Pro content with...
Track Demant and your other target companies to get real-time alerts and weekly summaries delivered straight to your inbox.
Browse news for competitors to Demant and other trending companies.